
Opinion|Videos|March 6, 2025
Switching Biologic Therapies in a 32-Year-Old Woman With Severe Atopic Dermatitis
Author(s)Naiem Issa, MD, PhD, FAAD
The panelist discusses how to evaluate the need for and manage the transition between biologic therapies in a 32-year-old woman with severe atopic dermatitis who has had an inadequate response to initial treatment.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
3
10 Skin Cancer Exam Tips
4
Dermatology Times Conferences & Meetings Calendar: September 2026
5





